The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Cann Regulatory News (OCTP)

Share Price Information for Oxford Cann (OCTP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.345
Bid: 0.33
Ask: 0.36
Change: -0.005 (-1.43%)
Spread: 0.03 (9.091%)
Open: 0.35
High: 0.35
Low: 0.345
Prev. Close: 0.35
OCTP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Second Price Monitoring Extn

7 Mar 2023 11:05

RNS Number : 1695S
Oxford Cannabinoid Tech.Holdings
07 March 2023
 

Second Price Monitoring Extension

A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes.

Following the first price monitoring extension this security would still have executed more than a pre-determined percentage above or below the price of the most recent automated execution today. London Stock Exchange electronic order book users have a final opportunity to review the prices and sizes of orders entered in this security prior to the auction execution.

The applicable percentage is set by reference to a security's Millennium Exchange sector. This is set out in the Sector Breakdown tab of the Parameters document at www.londonstockexchange.com/tradingservices

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
APMBBGDXUGGDGXR

Date   Source Headline
11th Apr 202411:26 amRNSAppointment of Phase I Clinical Trial CRO
3rd Apr 20248:00 amRNSOCT Company Update with Doceo
26th Mar 202410:56 amRNSOxford Cannabinoid Technologies video with Doceo
18th Mar 20247:00 amRNSAppointment of Hybridan as Adviser
29th Feb 20247:02 amRNSDirectorate Appointment
29th Feb 20247:01 amRNSDirectorate Changes
29th Feb 20247:00 amRNSTotal Voting Rights
28th Feb 20245:35 pmRNSTR-1: NOTIFICATION OF MAJOR HOLDINGS
28th Feb 20245:34 pmRNSTR-1: NOTIFICATION OF MAJOR HOLDINGS
28th Feb 20245:34 pmRNSTR-1: NOTIFICATION OF MAJOR HOLDINGS
26th Feb 20241:07 pmRNSDirectors’ Dealings
19th Feb 20241:52 pmRNSResult of General Meeting
16th Feb 20247:00 amRNSCompletion of Capital Reorganisation
15th Feb 20247:00 amRNSSubscription
14th Feb 202412:53 pmRNSCapital Reorganisation
9th Feb 20247:00 amRNSEdison issues update on OCTP
2nd Feb 20243:17 pmRNSNotice of General Meeting & Posting of Circular
2nd Feb 20243:13 pmRNSConvertible Loan Note Agreements
30th Jan 20247:04 amRNSFundraising and Proposed Capital Reorganisation
30th Jan 20247:02 amRNSR&D Tax Credit
30th Jan 20247:00 amRNSHalf-year Report
23rd Jan 20247:00 amRNSNotice of Results
10th Jan 20247:00 amRNSPatent Applications
14th Nov 20237:00 amRNSDirectorate Appointment
24th Oct 20237:00 amRNSTR-1: Notification of major holdings
20th Oct 20237:01 amRNSTR-1: Notification of major holdings
20th Oct 20237:00 amRNSDirector Dealing
10th Oct 20237:00 amRNSPhase I Clinical Trial Results
29th Sep 20237:00 amRNSResult of AGM
25th Sep 20237:00 amRNSFinal Dose Administered
5th Sep 20234:18 pmRNSNotice of AGM
31st Aug 20237:00 amRNS2023 Final Results
22nd Aug 20237:00 amRNSNotice of Results
27th Jul 20237:00 amRNSFirst Dose Administered & Pain Specialist Adviser
17th Jul 20231:16 pmRNSDirector/PDMR Share Purchases
17th Jul 20237:00 amRNSExpansion into oncology
12th Jul 20237:00 amRNSInvestor Presentation and Q&A – Programmes update
15th Jun 20239:50 amRNSOCTP update from Doceo
8th Jun 20237:00 amRNSAppointment of Chief Medical Officer
17th May 20237:00 amRNSMHRA & REC 2 Approval for Phase 1 Clinical Trial
12th Apr 20237:00 amRNSDirectorate Change, Renewal of Licence & Update
14th Mar 20232:05 pmRNSSecond Price Monitoring Extn
14th Mar 20232:00 pmRNSPrice Monitoring Extension
13th Mar 20234:35 pmRNSPrice Monitoring Extension
7th Mar 202311:05 amRNSSecond Price Monitoring Extn
7th Mar 202311:00 amRNSPrice Monitoring Extension
6th Mar 202311:05 amRNSSecond Price Monitoring Extn
6th Mar 202311:00 amRNSPrice Monitoring Extension
25th Jan 202312:09 pmRNSHolding in Company
23rd Jan 20237:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.